A

Arthritis Northwest, PLLC | Spokane, WA

Research site
(Unclaimed)
Location
105 West 8th Avenue Suite 6080, Spokane, Washington, United States of America

Site insights

Top conditions

Top treatments

Baricitinib
MTX
Peresolimab
LY3009104
Methotrexate
Guselkumab
Deucravacitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 9 total trials

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...

Active, not recruiting
Joint Diseases
Arthritis
Drug: Peresolimab
Drug: Placebo

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Enrolling
Sjögren's Syndrome
Drug: Deucravacitinib
Other: Placebo

The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus peglot...

Enrolling
Gout
Biological: Pegloticase
Drug: Methotrexate

This study is investigating the safety and efficacy of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (cHP).During the first 24...

Active, not recruiting
Chronic Hypoparathyroidism
Parathyroid Diseases
Combination Product: eneboparatide
Combination Product: Placebo

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate re...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

Trial sponsors

Amgen logo
Lilly logo
A
Bristol-Myers Squibb (BMS) logo
J

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems